← Eichor
Study identifier: NCT07399652 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures

Condition: Achalasia Cardia · Tumor  ·  Sponsor: Asian Institute of Gastroenterology, India

PhaseNA
Planned participants20
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This prospective study aims to evaluate the performance of a novel Artificial Intelligence (AI) clinical decision support tool during third space endoscopic procedures, such as Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM). While these procedures are effective for treating gastrointestinal neoplasms and motility disorders, they carry risks of intraprocedural bleeding and perforation if submucosal blood vessels are not correctly identified and coagulated. Building on previous retrospective validation, this study will assess whether a real-time artificial intelligence model can assist endoscopists in detecting and delineating blood vessels more accurately and faster during live human procedures.

This description comes directly from the study's public registry record.

Talk to the study team

Abhishek Tyagi, M.S.  ·  919989154556  ·  mr.tyagi@gmail.com

Mohan Ramchandani, M.D.  ·  919701335444  ·  ramchandanimohan@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Asian Institute of GastroenterologyHyderabad, Telangana, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07399652